Nurix Therapeutics Inc (NRIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 11/30
(Values in U.S. thousands)
| 02-2026 | 11-2025 | 08-2025 | 05-2025 | 02-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 71,195 | 246,960 | 78,438 | 84,260 | 75,916 |
| Marketable Securities | 469,537 | 345,981 | 350,391 | 401,521 | 473,764 |
| Receivables | N/A | N/A | N/A | 19,000 | N/A |
| TOTAL | $554,394 | $606,819 | $440,603 | $515,330 | $563,703 |
| Non-Current Assets | |||||
| PPE Net | 21,697 | 22,490 | 20,498 | 18,773 | 18,449 |
| Other Non-Current Assets | 60,039 | 58,826 | 61,371 | 57,452 | 32,891 |
| TOTAL | $81,736 | $81,316 | $81,869 | $76,225 | $51,340 |
| Total Assets | $636,130 | $688,135 | $522,472 | $591,555 | $615,043 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 10,293 | 11,215 | 8,609 | 5,954 | 8,397 |
| Accrued Expenses | 59,950 | 54,852 | 43,957 | 37,005 | 44,361 |
| TOTAL | $92,199 | $86,471 | $82,350 | $75,614 | $89,988 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 18,754 | 17,580 | 25,993 | 27,420 | 30,591 |
| Other Non-Current Liabilities | 55,453 | 52,906 | 52,695 | 46,696 | 19,984 |
| TOTAL | $63,038 | $62,917 | $67,870 | $68,338 | $44,138 |
| Total Liabilities | $155,237 | $149,388 | $150,220 | $143,952 | $134,126 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 103,406 | 102,843 | 76,883 | 76,449 | 76,236 |
| Common Shares | 103 | 102 | 77 | 76 | 76 |
| Retained earnings | -1,090,400 | -1,003,226 | -925,005 | -838,584 | -795,120 |
| Other shareholders' equity | 56 | 105 | 119 | -20 | 226 |
| TOTAL | $480,893 | $538,747 | $372,252 | $447,603 | $480,917 |
| Total Liabilities And Equity | $636,130 | $688,135 | $522,472 | $591,555 | $615,043 |